Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
New Approaches to Neuroblastoma Therapy Consortium
Dana-Farber Cancer Institute
Nationwide Children's Hospital
New Approaches to Neuroblastoma Therapy Consortium
Fundació Sant Joan de Déu
National Cancer Institute (NCI)
Baylor College of Medicine
Children's Oncology Group
St. Jude Children's Research Hospital
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)